This was confirmed by Western blots showing that treatment of neurons with AD AEVs did not result in increased levels of the apoptosis markers cleaved caspase-3 and -7, compared to treatment with AEVs from the control participants (Figure 4c,d). This evidence concerns the gene CASP3 and Alzheimer disease.